Bangladesh Labelling: Local Labels After Customs Clearance and MRP Rules

1. Key takeaways

Bangladesh allows imported devices to be labelled after customs clearance and before release for sale. Note 3 to §7.2 of the DGDA medical device registration guideline states that for medical devices imported into the country, the importer may further label the product while it is held in quarantine so that it complies with the labelling rules, after which it may be released for sale. The additional label must carry the importer’s name, the expiry date, the batch number and the maximum retail price in Bangladeshi taka.

This is a genuine concession. It means a manufacturer does not have to open a Bangladesh-specific packaging line, and can ship on globally standard packaging with the local particulars applied at destination. The concession is conditional on physical control of the goods, so the benefit depends on the importer’s warehouse as much as on the manufacturer’s artwork.

• Legal basis: §7.2 Note 3, labelling during quarantine before release for sale.
• Required particulars: importer name, expiry date, batch number, MRP in taka.
• Condition: the goods must be held under quarantine, physically separated from released stock.
• Sequencing: labelling and MRP approval both complete before sale, never after.
• MRP timing: approval takes 30 to 40 days, and the figure is not set by the company.

2. Legal basis

Section 7.2 sets the labelling rules, citing ISO standards and GHTF/SG1/N70:2011 for the marking requirements and ISO 15223-1:2007 for symbols, and its notes supply the operational detail. Note 1 requires the date of manufacture or the expiry date, or both. Note 2 places the labelling obligation on the bulk packaging where goods are supplied in bulk. Note 3 creates the quarantine route for imports. Beyond these, registration practice requires packaging materials to carry the brand, manufacturer name, country of origin, date of manufacture, expiry date and batch number, and the MRP itself is subject to a separate approval described in article 30 of this series.

The structure of the provision is worth noticing. The device arrives with its original labelling, and the local particulars are added on top, so the two layers have to coexist without contradicting each other, particularly on dates and batch identification.

3. Expert insights

Insight 1: Note 3 is the most useful provision in the Bangladeshi labelling regime. It removes the need for a separate packaging line for Bangladesh, since the globally used packaging can be shipped as it is and the local particulars applied after arrival under quarantine. For companies with a large SKU range and small order quantities, the saving is substantial, because a dedicated line only makes economic sense at volumes that most exporters to Bangladesh do not reach. It also shortens the change cycle: a revised importer name or a new MRP does not require a new print run at the factory, only a new local label.

Insight 2: quarantine is a legal concept, not a warehouse habit. The provision says the labelling is completed before release for sale, which requires the importer to have a controlled storage step in which unlabelled goods are physically separated from released goods. A warehouse that stores everything in one area cannot demonstrate that separation, and the labelling step then becomes the compliance gap rather than the compliance solution. In practice this is a question to settle at the qualification stage, not at the first shipment: whether the facility has a defined quarantine area, who controls access, and how the release is recorded.

Insight 3: the MRP must go through approval and must be shown in taka. The MRP is not a price the company sets for itself; it is a maximum retail price approved by DGDA, and the approval takes 30 to 40 days, as described in article 30. Selling above the approved MRP falls within the penalty framework for price offences. The consequence for planning is that the label cannot be completed at the moment of customs clearance, because the MRP figure is not yet known; the goods wait in quarantine for the approval as well as for the labelling.

Insight 4: the two labelling layers must agree. Importer name and MRP are new information, but the expiry date and batch number already exist on the original label. Where the added label repeats them, it must repeat them exactly, since a discrepancy between the factory label and the local label is difficult to explain and easy for an inspector to find.

4. Practical recommendations

GRZAN recommends preparing the local label template during registration rather than after clearance. The template carries the importer name, the expiry date, the batch number and a reserved position for the MRP, with the value inserted once DGDA has approved it. We describe the template within the packaging materials section of the dossier, so that the arrangement is visible to the reviewer at the point where labelling is assessed, and so that nobody has to design a label under time pressure at the port. We also ask the local partner to confirm in writing that its warehouse has a quarantine area, and to accept a contractual clause stating that goods may not be released for sale until labelling is complete and the MRP is approved.

• Design the local label early. Template approved during registration, MRP value added after approval.
• Reserve the MRP field. Leave the position and the format fixed so that only the number changes.
• Qualify the warehouse. Physical separation, access control and release records, confirmed in writing.
• Write the release condition into the agreement. No sale before labelling and MRP approval.
• Cite the note in the file. Reference §7.2 Note 3 where the labelling approach is described, so the route is explicit.

5. Verification checklist

• □ The Note 3 route is being used, with no separate packaging line opened
• □ Local label template includes importer name, expiry date, batch number and an MRP field
• □ Label complies with §7.2: ISO and GHTF marking, ISO 15223-1 symbols, date of manufacture or expiry
• □ Local warehouse confirmed to have a physical quarantine area
• □ Agreement states that goods may not be released for sale before labelling and MRP approval
• □ Bulk packaging labelled on the bulk pack in line with Note 2

Regulatory information verified as of 27 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Bangladesh. Our team prepares dossiers to DGDA expectations, manages submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com